Moomoo AI 已提取核心信息
Li Dean Y, Executive VP & President of Merck & Co's MRL division, completed a sale of 14,702 shares of the company's common stock on February 9, 2024. The shares were sold at an average price of $125.4988, resulting in a total transaction value of approximately $1.85 million. Following the sale, Li's direct holdings in Merck & Co. amounted to 46,242.37 shares. The transaction was executed as an open market or private sale, following an acquisition of the same number of shares through the exercise or conversion of derivative security at a price of $62.07 per share.
Li Dean Y, Executive VP & President of Merck & Co's MRL division, completed a sale of 14,702 shares of the company's common stock on February 9, 2024. The shares were sold at an average price of $125.4988, resulting in a total transaction value of approximately $1.85 million. Following the sale, Li's direct holdings in Merck & Co. amounted to 46,242.37 shares. The transaction was executed as an open market or private sale, following an acquisition of the same number of shares through the exercise or conversion of derivative security at a price of $62.07 per share.
默沙东公司MRL部门执行副总裁兼总裁李迪安于2024年2月9日完成了14,702股公司普通股的出售。这些股票的平均价格为125.4988美元，总交易额约为185万美元。出售后，李在默沙东的直接持股量为46,242.37股。该交易是通过行使或转换衍生证券以每股62.07美元的价格收购相同数量的股票后，以公开市场或私募方式执行的。
默沙东公司MRL部门执行副总裁兼总裁李迪安于2024年2月9日完成了14,702股公司普通股的出售。这些股票的平均价格为125.4988美元，总交易额约为185万美元。出售后，李在默沙东的直接持股量为46,242.37股。该交易是通过行使或转换衍生证券以每股62.07美元的价格收购相同数量的股票后，以公开市场或私募方式执行的。
有用
没用